Literature DB >> 26700872

DNMT3A, TET2, and JAK2 mutations in polycythemia vera following long-term remission of secondary acute myeloid leukemia.

Preetesh Jain1, Srdan Verstovsek1, Wei Wang2, Sanam Loghavi2, Harrys A Torres3, Zeev Estrov1, Keyur P Patel2, Naveen Pemmaraju1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26700872      PMCID： PMC4919228          DOI： 10.3109/10428194.2015.1122785

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  20 in total

1.  A rare case of polycythemia vera following acute undifferentiated leukemia remission.

Authors:  Hee-Jeong Youk; Chi-Hyun Cho; Jong-Han Lee; Chul Won Choi; Chae Seung Lim; Soo-Young Yoon
Journal:  Ann Lab Med       Date:  2014-10-28       Impact factor: 3.464

Review 2.  Canalization of development by microRNAs.

Authors:  Eran Hornstein; Noam Shomron
Journal:  Nat Genet       Date:  2006-06       Impact factor: 38.330

3.  DNMT3A mutations in myeloproliferative neoplasms.

Authors:  F Stegelmann; L Bullinger; R F Schlenk; P Paschka; M Griesshammer; C Blersch; S Kuhn; S Schauer; H Döhner; K Döhner
Journal:  Leukemia       Date:  2011-05-03       Impact factor: 11.528

4.  Clonal and lineage analysis of somatic DNMT3A and JAK2 mutations in a chronic phase polycythemia vera patient.

Authors:  Nisha Rao; Carolyn M Butcher; Ian D Lewis; David M Ross; Junia V Melo; Hamish S Scott; Peter G Bardy; Richard J D'Andrea
Journal:  Br J Haematol       Date:  2011-08-22       Impact factor: 6.998

5.  Development of polycythemia vera after chemotherapy-induced remission of acute myeloid leukemia: a case report.

Authors:  A Belotti; E Doni; E Elli; V Rossi; P Pioltelli; E M Pogliani
Journal:  Acta Haematol       Date:  2011-03-31       Impact factor: 2.195

6.  Correlation of mutation profile and response in patients with myelofibrosis treated with ruxolitinib.

Authors:  Keyur P Patel; Kate J Newberry; Rajyalakshmi Luthra; Elias Jabbour; Sherry Pierce; Jorge Cortes; Rajesh Singh; Meenakshi Mehrotra; Mark J Routbort; Madan Luthra; Taghi Manshouri; Fabio P Santos; Hagop Kantarjian; Srdan Verstovsek
Journal:  Blood       Date:  2015-06-29       Impact factor: 22.113

7.  Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis.

Authors:  Ayalew Tefferi; Paola Guglielmelli; Dirk R Larson; Christy Finke; Emnet A Wassie; Lisa Pieri; Naseema Gangat; Rajmonda Fjerza; Alem A Belachew; Terra L Lasho; Rhett P Ketterling; Curtis A Hanson; Alessandro Rambaldi; Guido Finazzi; Juergen Thiele; Tiziano Barbui; Animesh Pardanani; Alessandro M Vannucchi
Journal:  Blood       Date:  2014-07-18       Impact factor: 22.113

8.  Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms.

Authors:  Pontus Lundberg; Axel Karow; Ronny Nienhold; Renate Looser; Hui Hao-Shen; Ina Nissen; Sabine Girsberger; Thomas Lehmann; Jakob Passweg; Martin Stern; Christian Beisel; Robert Kralovics; Radek C Skoda
Journal:  Blood       Date:  2014-01-29       Impact factor: 22.113

9.  Leucocytosis in polycythaemia vera predicts both inferior survival and leukaemic transformation.

Authors:  Naseema Gangat; Jacob Strand; Chin-Yang Li; Wenting Wu; Animesh Pardanani; Ayalew Tefferi
Journal:  Br J Haematol       Date:  2007-08       Impact factor: 6.998

10.  Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.

Authors:  J Nangalia; C E Massie; E J Baxter; F L Nice; G Gundem; D C Wedge; E Avezov; J Li; K Kollmann; D G Kent; A Aziz; A L Godfrey; J Hinton; I Martincorena; P Van Loo; A V Jones; P Guglielmelli; P Tarpey; H P Harding; J D Fitzpatrick; C T Goudie; C A Ortmann; S J Loughran; K Raine; D R Jones; A P Butler; J W Teague; S O'Meara; S McLaren; M Bianchi; Y Silber; D Dimitropoulou; D Bloxham; L Mudie; M Maddison; B Robinson; C Keohane; C Maclean; K Hill; K Orchard; S Tauro; M-Q Du; M Greaves; D Bowen; B J P Huntly; C N Harrison; N C P Cross; D Ron; A M Vannucchi; E Papaemmanuil; P J Campbell; A R Green
Journal:  N Engl J Med       Date:  2013-12-10       Impact factor: 91.245
View more
  2 in total

1.  The extracellular signal-regulated kinase 1/2 modulates the intracellular localization of DNA methyltransferase 3A to regulate erythrocytic differentiation.

Authors:  Po-Shu Tu; Eric Chang-Yi Lin; Hsiao-Wen Chen; Shuoh-Wen Chen; Ting-An Lin; Jyh-Pyng Gau; Yuan-I Chang
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

Review 2.  Epigenetic Regulations in Neural Stem Cells and Neurological Diseases.

Authors:  Hang Zhou; Bin Wang; Hao Sun; Xingshun Xu; Yongxiang Wang
Journal:  Stem Cells Int       Date:  2018-03-18       Impact factor: 5.443
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.